1-3 of 3
F. Bauduer
Close
Sort by
Journal Articles

Low Doses of Thalidomide (Thal) in Low Risk MDS with Transfusion-Dependant Anemia: The GFM THAL-SMD-200 Trial.

J. Tamburini, C. Elie, D. Vassilief, M.C. Quarre, O. Beyne-Rauzy, M. Gardembas, A. Aouba, C. Berthou, L. Sanhes, A. Guerci, A. Stamatoullas, F. Bauduer, J.J. Sotto, L. Legros, S. Vaultier, P. Fenaux, F. Dreyfus, D. Bouscary
Journal: Blood
Blood (2006) 108 (11): 2673.
https://doi.org/10.1182/blood.V108.11.2673.2673
Published: 2006
Journal Articles

Is There a Role for ATRA in Combination to EPO in Lower Risk Myelodysplastic Syndrome? Preliminary Results of a Phase II Study.

L. Ades, H. Mohamed, D. Vassilief, E. Berger, B. Slama, N. Vey, R. Delarue, O. Beyne-Rauzy, A. Guerci, S. Cheze, X. Thomas, A. Stamatoullas, M. Gardembas, F. Bauduer, A. Kolb, M.C. Chaury, L. Legros, G. Damaj, F. Hamza, S. Vaultier, F. Dreyfus, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 2537.
https://doi.org/10.1182/blood.V106.11.2537.2537
Published: 2005
Journal Articles

Thalidomide for the Treatment of Low Risk Myelodysplasia.

D. Bouscary, MD-PhD, M. C. Quarre, MD, D. Vassilief, MD, O. Beyne Rouzy, MD, A. Aouba, MD, C. Berthou, MD, C. Gardembas, MD, L. Sanhes, MD, A. Guerci, MD, B. Mahe, MD, A. Stamatoullas, MD, F. Bauduer, MD, J. J. Sotto, MD, L. Legros, MD-PhD, S. Vaultier, ARC, P. Fenaux, MD-PhD, F. Dreyfus, MD
Journal: Blood
Blood (2004) 104 (11): 1438.
https://doi.org/10.1182/blood.V104.11.1438.1438
Published: 2004